Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 72 (28.6%)ASK Investment₹ 895 (-3.2%)AVPL ₹ 49 (0%)Bootes Impex₹ 775 (-8.8%)CIAL ₹ 442 (-0.5%)CSK ₹ 254 (-3.1%)ESDS Software₹ 478 (2.8%)Garuda Aerospace₹ 468 (-2.1%)Goodluck Defence₹ 385 (16%)Hero Motors₹ 325 (0%)Hinduja Leyland₹ 248 (0%)ICL Fincorp₹ 25 (0%)Incred Holdings₹ 154 (2.7%)Kineco Limited₹ 3285 (0%)Lava ₹ 60 (15.4%)Market Simplified₹ 26 (-7.1%)Matrix Gas₹ 12 (-20%)Motilal Oswal₹ 12.25 (-2%)MSEI ₹ 6.35 (-2.3%)NCDEX ₹ 368 (-1.6%)NSE ₹ 1985 (-2%)Onix Renewable₹ 68 (21.4%)OYO ₹ 23 (-4.2%)OYO Assets₹ 9.25 (-7%)Philips India₹ 1250 (0%)Polymatech Electronics₹ 56 (-3.4%)SBI Mutual₹ 768 (-0.9%)Taparia Tools₹ 6050 (0%)VCI Chemical₹ 64 (0%)Zepto ₹ 40 (-4.8%)

15 Days Price Change

Quest Laboratories IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds

WEBSITE Inc. Year: 1998 Industry: Pharmaceuticals & Drugs Listed Page

Profile
Issue Size --
Profile
Price Range 93  to  97 per share
Profile
Min Investment ₹97
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus --
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Quest Laboratories Ltd is a leading provider of diagnostic testing services, specializing in clinical laboratory testing, pathology, and molecular diagnostics. Established with a commitment to accuracy and efficiency, Quest Labs offers a comprehensive range of tests for healthcare providers, hospitals, and patients worldwide. With state-of-the-art facilities and a team of skilled professionals, the company delivers timely and reliable results, aiding in the diagnosis and management of various medical conditions. Quest Laboratories is dedicated to advancing healthcare through innovative technologies and rigorous quality standards, ensuring the highest level of service and patient care. Read More

Basic Info

Face Value 10 per share

Price 93  to  97 per share

P/E (x) 11.7

Sales( Cr.) 104

PAT( Cr.) 14

EPS 8.3

Draft Prospectus --

Exchange NSE-SME

Promoter

Company Promoters

Mr. Anil Kumar Sabarwal Ms. Tejaswini Sabarwal.

Pre Issue Share Holding 91.57%

Post Issue Share Holding 65.99%

Listing Details:

Listing Price: 155.1

Listing Gain: 37.46%

Current Price: 117

Gain On Issue: 117 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date May 15, 2024
Closing Date May 17, 2024
Allotment May 20, 2024
Refund May 21, 2024
Delivery of Shares May 21, 2024
Listing Date May 22, 2024

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 1200 116,400
Retail (Max) 1 1200 116,400
S-HNI (Min) 2 2400 232,800
S-HNI (Max) 8 9600 931,200
B-HNI (Min) 9 10800 1,047,600

Objective of the Issue

1. Funding of capital expenditure towards purchase of plant and machinery for expansion at the existing manufacturing facility 2. Funding working capital requirements of the company 3. General corporate purposes

Issue

Category Nos Bid Bid (x)
QIB 2224800 127258560 57.2x
NII 667440 122875704 184.1x
Retail 1557360 89750657 57.6x
EMP 0 0 0x
Total 4449600 379372896 85.3x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Quest Laboratories Profit & Loss

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 30 59 62 83 104
Other Income 0 0 0 0 4
Total Income 30 60 62 83 108
Total Expenditure 29 53 54 67 88
Operating Profit 1 7 8 16 20
Interest 0 0 1 1 1
Depreciation 0 0 1 1 1
Exceptional Income / Expenses 0 0 0 0 0
Profit Before Tax 1 6 7 14 19
Provision for Tax 0 2 2 4 5
Profit After Tax 1 4 5 10 14
Adjustments 0 0 0 0 0
Profit After Adjustments 1 4 5 10 14
Adjusted Earnings Per Share 0.6 3.8 4.7 8.5 8.3

Quest Laboratories Balance Sheet

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 6 10 15 29 82
Minority's Interest 0 0 0 0 0
Borrowings 1 1 2 1 1
Other Non-Current Liabilities 0 1 1 1 1
Total Current Liabilities 11 23 29 30 37
Total Liabilities 18 35 47 61 122
Fixed Assets 6 7 10 10 12
Other Non-Current Assets 0 1 3 0 3
Total Current Assets 12 27 34 50 107
Total Assets 18 35 47 61 122

Quest Laboratories Cash Flow

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 1 0 0 0 0
Cash Flow from Operating Activities 1 3 4 3 -23
Cash Flow from Investing Activities -1 -2 -4 -5 -44
Cash Flow from Financing Activities 0 -0 0 2 67
Net Cash Inflow / Outflow -0 1 0 0 -0
Closing Cash & Cash Equivalent 0 2 0 0 0

Quest Laboratories Ratios

# Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0.61 3.81 4.68 8.46 8.28
CEPS(Rs) 0.97 4.23 5.19 8.93 8.67
DPS(Rs) 0 0 0 0 0
Book NAV/Share(Rs) 5.46 9.26 14 24.01 49.92
Core EBITDA Margin(%) 4.67 10.87 12.73 18.85 15.37
EBIT Margin(%) 3.61 10.19 12.2 18.44 18.84
Pre Tax Margin(%) 2.6 9.69 11.33 17.5 17.97
PAT Margin (%) 2.16 6.9 8.18 12.23 13.05
Cash Profit Margin (%) 3.45 7.67 9.08 12.91 13.66
ROA(%) 3.56 15.43 12.34 18.78 14.89
ROE(%) 11.12 51.69 40.21 46.13 24.56
ROCE(%) 12.28 55 46.54 57.51 26.87
Receivable days 110.05 95.77 124.35 98.1 95.62
Inventory Days 9.95 5.88 36.25 60.3 65.81
Payable days 118.86 102.6 181.85 157.99 60.76
PER(x) 0 0 0 0 12.38
Price/Book(x) 0 0 0 0 2.05
Dividend Yield(%) 0 0 0 0 0
EV/Net Sales(x) 0.12 0.04 0.08 0.2 1.9
EV/Core EBITDA(x) 2.48 0.4 0.63 1.07 9.79
Net Sales Growth(%) 0 95.91 3.63 33.94 25.92
EBIT Growth(%) 0 452.92 24.03 102.46 28.67
PAT Growth(%) 0 526.72 22.9 100.08 34.4
EPS Growth(%) 0 526.68 22.9 80.81 -2.09
Debt/Equity(x) 0.52 0.31 0.27 0.18 0.37
Current Ratio(x) 1.1 1.17 1.16 1.67 2.88
Quick Ratio(x) 1.03 1.12 0.78 1.13 2.3
Interest Cover(x) 3.57 20.45 13.97 19.54 21.63
Total Debt/Mcap(x) 0 0 0 0 0.18

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 25% 21% 0% 0%
Operating Profit CAGR 25% 42% 0% 0%
PAT CAGR 40% 52% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 40% NA% NA% NA%
ROE Average 25% 37% 35% 35%
ROCE Average 27% 44% 40% 40%

Company Contact Information

Quest Laboratories Ltd.

Plot No. 45 Opp Kissan Pipe Unit 4 Sector I I I Pithampur

IPO Lead Manager(s)

Quest Laboratories Ltd.

Shreni Shares Limited

Registrar Info

Quest Laboratories Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Error!